[A case with advanced carcinoma of the gallbladder responding to UFT monotherapy]

Gan To Kagaku Ryoho. 2005 Apr;32(4):529-31.
[Article in Japanese]

Abstract

Gallbladder carcinoma is a fatal disease with highly metastatic potential, and the chemotherapeutic regimen has not been established yet. We reported here a case of gallbladder carcinoma with lung and liver meatstases responding to a single agent, UFT. A 70-year-old female with advanced carcinoma of the gallbladder and bilateral pulmonary metastases were treated with UFT 600 mg/day weekday for half a year. Pulmonary metastases disappeared completely, and the primary lesion shrank markedly 6 months after. Unfortunately, the patient died 1.5 years after the start of treatment due to relapse of liver and lung lesions.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adenocarcinoma, Papillary / drug therapy*
  • Adenocarcinoma, Papillary / secondary
  • Administration, Oral
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Drug Combinations
  • Female
  • Gallbladder Neoplasms / drug therapy*
  • Gallbladder Neoplasms / pathology
  • Humans
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary
  • Quality of Life
  • Tegafur / therapeutic use*
  • Uracil / therapeutic use*

Substances

  • Antineoplastic Agents
  • Drug Combinations
  • UFT(R) drug
  • Tegafur
  • Uracil